|
시장보고서
상품코드
1605879
DNA 진단 시장 : 시장 규모, 점유율, 동향, 산업 분석 보고서-제공별, 기술별, 검체별, 용도별, 최종 사용자별, 지역별-시장 예측(2025-2034년)DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering, Technology, Specimen, Application, End User, and Region - Market Forecast, 2025 - 2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면 세계의 DNA 진단 시장 규모는 2034년까지 313억 1,000만 달러에 이를 것으로 예상됩니다. 이 조사 보고서는 현재의 시장 역학을 자세히 파악하여 미래 시장 성장에 대한 분석을 제공합니다.
DNA 진단 시장의 확대는 세계 유전성 질환의 유병률 상승이 원동력이 되고 있습니다. 세계보건기구(WHO)는 단일 유전자 변이에 의해 발생하는 단발성 질환은 약 10,000가지가 있다고 추정하고 있습니다. 세계 유병률은 1,000명당 약 10명으로, 7,000만 명에서 8,000만 명이 유전성 질환에 이환되어 있는 셈입니다. 이러한 유전자 질환의 급증으로 유전자 질환을 검출하고 평가하기 위한 효율적인 도구에 대한 수요가 높아지고 있습니다. 그 결과 희귀 유전성 질환, 유전성 암, 유전성 대사 이상의 이환율 증가가 진단 기술의 진보를 촉진하고 DNA 진단 시장을 자극하고 있습니다.
DNA 진단 시장은 유전체 기술의 진보로 유전자 검사의 정확성, 속도, 가격이 향상되어 큰 성장을 이루고 있습니다. 예를 들어 2024년 5월 유전체 연구 및 기술 기업인 바이오아로는 인간 게놈의 복잡성을 실시간으로 분석하는 소프트웨어 PanOmiQ를 발표했습니다. 이러한 기술적 강화를 통해 상세한 게놈 해석이 용이해지며, 보다 상세하고 신뢰성 높은 진단 결과를 얻을 수 있게 됩니다. 이처럼 게놈 기술의 지속적인 진화는 새로운 진단 도구와 진단 방법의 개발을 지원함으로써 DNA 진단 시장의 성장을 촉진하고 있습니다.
헬스케어 기업은 기술 혁신, 연구, 새로운 진단 기술의 진보를 촉진하기 위해 자금 투자를 확대하고 있습니다. 이러한 투자는, 게놈 연구의 진전, 검사 수법의 개량, DNA 진단의 정밀도와 신뢰성의 향상을 뒷받침하고 있습니다. 그 결과 기업의 투자는 연구기관과의 협력과 헬스케어 진료에 대한 유전자 검사 통합을 가속화하고 세계 DNA 진단약 시장의 확대를 촉구하고 있습니다.
DNA 진단 시장 보고서 하이라이트
시약 및 키트 분야는 유전자 검사용으로 조정된 종합적인 스위트 시장발에 의해 세계 시장에서 대폭적인 CAGR의 성장이 전망됩니다.
2023년에는 암세계의 유병률 증가로 암 유전자 검사 분야가 최대 시장 점유율을 차지했습니다.
2023년 북미는 확립된 기관과 견고한 헬스케어 인프라가 존재하기 때문에 매출에서 세계 DNA 진단 시장을 독점했습니다.
중국의 DNA 진단 시장은 생명공학과 헬스케어 인프라에 대한 투자가 증가하고 있기 때문에 상당한 성장이 예상되고 있습니다.
세계 주요 시장 기업은 Abbott; Agilent Technologies, Inc.; Avalon GloboCare Corp.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Cepheid; F. Hoffmann-La Roche Ltd; GE HealthCare; Hologic, Inc.; Illumina, Inc.; QIAGEN; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc. 입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 DNA 진단 시장 인사이트
- 시장 현황
- DNA 진단 시장 역학
- 성장 촉진요인 및 기회
- DNA 진단 서비스의 확대가 시장 성장 견인
- 헬스케어 기업에 의한 투자가 시장 규모 촉진
- 억제요인 및 과제
- 엄격한 규제 요건이 시장 확대에 영향
- 성장 촉진요인 및 기회
- PESTEL 분석
- DNA 진단 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 DNA 진단 시장 : 제공별
- 주요 조사 결과
- 서문
- 기기
- 시약 및 키트
- 서비스 및 소프트웨어
제6장 세계의 DNA 진단 시장 : 기술별
- 주요 조사 결과
- 서문
- 인사이츄 하이브리드화
- 질량 분석
- 마이크로어레이
- 중합효소 연쇄반응(PCR)
- 시퀀싱
- 기타
제7장 세계의 DNA 진단 시장 : 검체별
- 주요 조사 결과
- 서문
- 혈액, 혈청 및 혈장
- 소변
- 기타
제8장 세계의 DNA 진단 시장 : 용도별
- 주요 조사 결과
- 서문
- 암 유전자 검사
- 감염증 DNA 검사
- 신생아 유전자 스크리닝
- 착상 전 진단과 생식 진단
- 비감염성 질환의 DNA 검사
- 혈액학 및 면역학, 신원 진단 및 법의학
- 약리 유전체학 및 약물 대사
- 출생 전 DNA 캐리어 스크리닝
- 기타
제9장 세계의 DNA 진단 시장 : 최종 사용자별
- 주요 조사 결과
- 서문
- 진단 실험실
- 병원 및 진료소
- 기타
제10장 세계의 DNA 진단 시장 : 지역별
- 주요 조사 결과
- 서문
- DNA 진단 시장 평가 : 지역별(2020-2034년)
- 북미
- 북미 : 제공별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 북미 : 검체별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종 사용자별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제공별(2020-2034년)
- 유럽 : 테크놀로지별(2020-2034년)
- 유럽 : 검체별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종 사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제공별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양 : 검체별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종 사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제공별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카 : 검체별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종 사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제공별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 검체별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종 사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제11장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제12장 기업 프로파일
- Abbott
- Agilent Technologies, Inc.
- Avalon GloboCare Corp.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Cepheidc
- F. Hoffmann-La Roche Ltd
- GE HealthCare
- Hologic, Inc.
- Illumina, Inc.
- Siemens Healthcare Private Limited
- Thermo Fisher Scientific Inc.
The global DNA diagnostics market size is expected to reach USD 31.31 billion by 2034, according to a new study by Polaris Market Research. The report "DNA Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Offering (Instruments, Reagents & Kits, and Services & Software), Technology, Specimen, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The expansion of the DNA diagnostics market is being driven by the rising prevalence of genetic disorders worldwide. The World Health Organization (WHO) estimated that there are around 10,000 different types of monogenic diseases caused by mutations in a single gene. The global prevalence rate is approximately 10 per 1000 individuals, indicating that between 70 million and 80 million people are affected by genetic disorders. This surge in genetic conditions has created an increased demand for efficient tools to detect and evaluate genetic disorders. Consequently, the growing incidence of rare genetic diseases, hereditary cancers, and inherited metabolic disorders is propelling the advancement of diagnostic technologies, thereby stimulating the DNA diagnostics market.
The market for DNA diagnostics is experiencing significant growth due to the advancements in genomic technology, which have improved the accuracy, speed, and affordability of genetic testing. For instance, in May 2024, BioAro, a genomic research and technology company, launched PanOmiQ, a software that provides real-time insights into the complexities of the human genome. These types of technological enhancements facilitate in-depth genome analysis, resulting in more detailed and dependable diagnostic outcomes. Thus, the ongoing evolution of genomic technologies is driving the growth of the DNA diagnostics market by supporting the development of new diagnostic tools and methods.
Healthcare firms are escalating their financial investments to drive innovation, research, and the advancement of new diagnostic technologies. These investments are empowering companies to progress genomic research, refine testing methodologies, and enhance the precision and dependability of DNA diagnostics. Consequently, company investments are accelerating collaborations with research institutions and the integration of genetic testing into healthcare practices, thereby stimulating the expansion of the global DNA diagnostics market.
DNA Diagnostics Market Report Highlights
The reagents and kits segment is expected to grow with a substantial CAGR in the global market, driven by the development of comprehensive suites tailored for genetic testing.
In 2023, the cancer genetics tests segment accounted for the largest market share because of the increasing prevalence of cancer globally.
In 2023, North America dominated the global DNA diagnostics market in terms of revenue due to the presence of well-established institutions and a robust healthcare infrastructure in the region.
The DNA diagnostics market in China is expected to grow substantially because of the country's increasing investment in biotechnology and healthcare infrastructure.
The global key market players are Abbott; Agilent Technologies, Inc.; Avalon GloboCare Corp.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Cepheid; F. Hoffmann-La Roche Ltd; GE HealthCare; Hologic, Inc.; Illumina, Inc.; QIAGEN; Siemens Healthcare Private Limited; and Thermo Fisher Scientific Inc.
Polaris Market Research has segmented the DNA diagnostics market report based on offering, technology, specimen, application, end user, and region:
By Offering Outlook (Revenue - USD Billion, 2019 - 2032)
- Instruments
- Reagents & Kits
- Services & Software
By Technology Outlook (Revenue - USD Billion, 2019 - 2032)
- In Situ Hybridization
- Mass Spectroscopy
- Microarrays
- Polymerase Chain Reaction (PCR)
- Sequencing
- Others
By Specimen Outlook (Revenue - USD Billion, 2019 - 2032)
- Blood, Serum, and Plasma
- Urine
- Others
By Application Outlook (Revenue - USD Billion, 2019 - 2032)
- Cancer Genetics Tests
- Infectious Diseases DNA Testing
- CT/NG Diagnostic
- HBV Diagnostic
- HCV Diagnostic
- HIV Diagnostic
- HPV Diagnostic
- MRSA Diagnostic
- TB Diagnostic
- Others
- Newborn Genetic Screening
- Preimplantation & Reproductive Diagnosis
- Non-Infectious Diseases DNA Testing
- Cardiovascular Diseases
- CNS & PNS Related
- Lung, Kidney, Liver & GT Related
- Sensory Diseases
- Skeletal, Connective, Ectodermal & Dermal DNA Testing
- Hematology & Immunology/Identity Diagnostics & Forensics
- Pharmacogenomics/Drug Metabolism
- Prenatal DNA Carrier Screening
- Others
By End User Outlook (Revenue - USD Billion, 2019 - 2032)
- Diagnostic laboratories
- Hospitals & clinics
- Others
By Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Australia
- Rest of APAC
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of MEA
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global DNA Diagnostics Market Insights
- 4.1. DNA Diagnostics Market - Market Snapshot
- 4.2. DNA Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Expansion of DNA Testing Services Are Driving Market Growth
- 4.2.1.2. Investments by Healthcare Companies Are Propelling Market Size
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Stringent Regulatory Requirements Affects the Market Expansion
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. DNA Diagnostics Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global DNA Diagnostics Market, by Offering
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 5.3. Instruments
- 5.3.1. Global DNA Diagnostics Market, by Instruments, by Region, 2020-2034 (USD billion)
- 5.4. Reagents & Kits
- 5.4.1. Global DNA Diagnostics Market, by Reagents & Kits, by Region, 2020-2034 (USD billion)
- 5.5. Services & Software
- 5.5.1. Global DNA Diagnostics Market, by Services & Software, by Region, 2020-2034 (USD billion)
6. Global DNA Diagnostics Market, by Technology
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 6.3. In Situ Hybridization
- 6.3.1. Global DNA Diagnostics Market, by In Situ Hybridization, by Region, 2020-2034 (USD billion)
- 6.4. Mass Spectroscopy
- 6.4.1. Global DNA Diagnostics Market, by Mass Spectroscopy, by Region, 2020-2034 (USD billion)
- 6.5. Microarrays
- 6.5.1. Global DNA Diagnostics Market, by Microarrays, by Region, 2020-2034 (USD billion)
- 6.6. Polymerase Chain Reaction (PCR)
- 6.6.1. Global DNA Diagnostics Market, by Polymerase Chain Reaction (PCR), by Region, 2020-2034 (USD billion)
- 6.7. Sequencing
- 6.7.1. Global DNA Diagnostics Market, by Sequencing, by Region, 2020-2034 (USD billion)
- 6.8. Others
- 6.8.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
7. Global DNA Diagnostics Market, by Specimen
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 7.3. Blood, Serum, and Plasma
- 7.3.1. Global DNA Diagnostics Market, by Blood, Serum, and Plasma, by Region, 2020-2034 (USD billion)
- 7.4. Urine
- 7.4.1. Global DNA Diagnostics Market, by Urine, by Region, 2020-2034 (USD billion)
- 7.5. Others
- 7.5.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
8. Global DNA Diagnostics Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 8.3. Cancer Genetics Tests
- 8.3.1. Global DNA Diagnostics Market, by Cancer Genetics Tests, by Region, 2020-2034 (USD billion)
- 8.4. Infectious Diseases DNA Testing
- 8.4.1. Global DNA Diagnostics Market, by Infectious Diseases DNA Testing, by Region, 2020-2034 (USD billion)
- 8.4.2. CT/NG Diagnostic
- 8.4.2.1. Global DNA Diagnostics Market, by CT/NG Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.3. HBV Diagnostic
- 8.4.3.1. Global DNA Diagnostics Market, by HBV Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.4. HCV Diagnostic
- 8.4.4.1. Global DNA Diagnostics Market, by HCV Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.5. HIV Diagnostic
- 8.4.5.1. Global DNA Diagnostics Market, by HIV Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.6. HPV Diagnostic
- 8.4.6.1. Global DNA Diagnostics Market, by HPV Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.7. MRSA Diagnostic
- 8.4.7.1. Global DNA Diagnostics Market, by MRSA Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.8. TB Diagnostic
- 8.4.8.1. Global DNA Diagnostics Market, by TB Diagnostic, by Region, 2020-2034 (USD billion)
- 8.4.9. Others
- 8.4.9.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
- 8.5. Newborn Genetic Screening
- 8.5.1. Global DNA Diagnostics Market, by Newborn Genetic Screeningc, by Region, 2020-2034 (USD billion)
- 8.6. Preimplantation & Reproductive Diagnosis
- 8.6.1. Global DNA Diagnostics Market, by Preimplantation & Reproductive Diagnosis, by Region, 2020-2034 (USD billion)
- 8.7. Non-Infectious Diseases DNA Testing
- 8.7.1. Global DNA Diagnostics Market, by Non-Infectious Diseases DNA Testing, by Region, 2020-2034 (USD billion)
- 8.7.2. Cardiovascular Diseases
- 8.7.2.1. Global DNA Diagnostics Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD billion)
- 8.7.3. CNS & PNS Related
- 8.7.3.1. Global DNA Diagnostics Market, by CNS & PNS Related, by Region, 2020-2034 (USD billion)
- 8.7.4. Lung, Kidney, Liver & GT Related
- 8.7.4.1. Global DNA Diagnostics Market, by Lung, Kidney, Liver & GT Related, by Region, 2020-2034 (USD billion)
- 8.7.5. Sensory Diseases
- 8.7.5.1. Global DNA Diagnostics Market, by Sensory Diseases, by Region, 2020-2034 (USD billion)
- 8.7.6. Skeletal, Connective, Ectodermal & Dermal DNA Testing
- 8.7.6.1. Global DNA Diagnostics Market, by Skeletal, Connective, Ectodermal & Dermal DNA Testing, by Region, 2020-2034 (USD billion)
- 8.8. Hematology & Immunology/Identity Diagnostics & Forensics
- 8.8.1. Global DNA Diagnostics Market, by Hematology & Immunology/Identity Diagnostics & Forensics, by Region, 2020-2034 (USD billion)
- 8.9. Pharmacogenomics/Drug Metabolism
- 8.9.1. Global DNA Diagnostics Market, by Pharmacogenomics/Drug Metabolism, by Region, 2020-2034 (USD billion)
- 8.10. Prenatal DNA Carrier Screening
- 8.10.1. Global DNA Diagnostics Market, by Prenatal DNA Carrier Screening, by Region, 2020-2034 (USD billion)
- 8.11. Others
- 8.11.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
9. Global DNA Diagnostics Market, by End User
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 9.3. Diagnostic Laboratories
- 9.3.1. Global DNA Diagnostics Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD billion)
- 9.4. Hospitals & clinics
- 9.4.1. Global DNA Diagnostics Market, by Hospitals & clinics, by Region, 2020-2034 (USD billion)
- 9.5. Others
- 9.5.1. Global DNA Diagnostics Market, by Others, by Region, 2020-2034 (USD billion)
10. Global DNA Diagnostics Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. DNA Diagnostics Market Assessment, By Geography, 2020-2034 (USD billion)
- 10.3. DNA Diagnostics Market - North America
- 10.3.1. North America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.3.2. North America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.3.3. North America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.3.4. North America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.3.5. North America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.3.7. DNA Diagnostics Market - U.S.
- 10.3.7.1. U.S.: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.3.7.2. U.S.: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.3.7.3. U.S.: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.3.7.4. U.S.: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.3.7.5. U.S.: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.3.8. DNA Diagnostics Market - Canada
- 10.3.8.1. Canada: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.3.8.2. Canada: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.3.8.3. Canada: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.3.8.4. Canada: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.3.8.5. Canada: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4. DNA Diagnostics Market - Europe
- 10.4.1. Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.2. Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.3. Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.4. Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.5. Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.6. DNA Diagnostics Market - UK
- 10.4.6.1. UK: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.6.2. UK: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.6.3. UK: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.6.4. UK: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.6.5. UK: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.7. DNA Diagnostics Market - France
- 10.4.7.1. France: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.7.2. France: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.7.3. France: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.7.4. France: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.7.5. France: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.8. DNA Diagnostics Market - Germany
- 10.4.8.1. Germany: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.8.2. Germany: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.8.3. Germany: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.8.4. Germany: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.8.5. Germany: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.9. DNA Diagnostics Market - Italy
- 10.4.9.1. Italy: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.9.2. Italy: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.9.3. Italy: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.9.4. Italy: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.9.5. Italy: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.10. DNA Diagnostics Market - Spain
- 10.4.10.1. Spain: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.10.2. Spain: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.10.3. Spain: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.10.4. Spain: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.10.5. Spain: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.11. DNA Diagnostics Market - Netherlands
- 10.4.11.1. Netherlands: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.11.2. Netherlands: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.11.3. Netherlands: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.11.4. Netherlands: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.11.5. Netherlands: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.12. DNA Diagnostics Market - Russia
- 10.4.12.1. Russia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.12.2. Russia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.12.3. Russia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.12.4. Russia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.12.5. Russia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.4.13. DNA Diagnostics Market - Rest of Europe
- 10.4.13.1. Rest of Europe: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.4.13.2. Rest of Europe: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.4.13.3. Rest of Europe: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.4.13.4. Rest of Europe: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.4.13.5. Rest of Europe: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5. DNA Diagnostics Market - Asia Pacific
- 10.5.1. Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.2. Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.3. Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.4. Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.5. Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.6. DNA Diagnostics Market - China
- 10.5.6.1. China: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.6.2. China: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.6.3. China: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.6.4. China: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.6.5. China: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.7. DNA Diagnostics Market - India
- 10.5.7.1. India: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.7.2. India: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.7.3. India: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.7.4. India: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.7.5. India: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.8. DNA Diagnostics Market - Malaysia
- 10.5.8.1. Malaysia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.8.2. Malaysia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.8.3. Malaysia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.8.4. Malaysia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.8.5. Malaysia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.9. DNA Diagnostics Market - Japan
- 10.5.9.1. Japan: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.9.2. Japan: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.9.3. Japan: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.9.4. Japan: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.9.5. Japan: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.10. DNA Diagnostics Market - Indonesia
- 10.5.10.1. Indonesia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.10.2. Indonesia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.10.3. Indonesia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.10.4. Indonesia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.10.5. Indonesia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.11. DNA Diagnostics Market - South Korea
- 10.5.11.1. South Korea: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.11.2. South Korea: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.11.3. South Korea: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.11.4. South Korea: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.11.5. South Korea: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.12. DNA Diagnostics Market - Australia
- 10.5.12.1. Australia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.12.2. Australia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.12.3. Australia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.12.4. Australia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.12.5. Australia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.5.13. DNA Diagnostics Market - Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.5.13.2. Rest of Asia Pacific: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.5.13.3. Rest of Asia Pacific: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.5.13.4. Rest of Asia Pacific: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.5.13.5. Rest of Asia Pacific: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6. DNA Diagnostics Market - Middle East & Africa
- 10.6.1. Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.6.2. Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.6.3. Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.6.4. Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.6.5. Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.6. DNA Diagnostics Market - Saudi Arabia
- 10.6.6.1. Saudi Arabia: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.6.6.2. Saudi Arabia: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.6.6.3. Saudi Arabia: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.6.6.4. Saudi Arabia: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.6.6.5. Saudi Arabia: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.7. DNA Diagnostics Market - UAE
- 10.6.7.1. UAE: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.6.7.2. UAE: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.6.7.3. UAE: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.6.7.4. UAE: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.6.7.5. UAE: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.8. DNA Diagnostics Market - Israel
- 10.6.8.1. Israel: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.6.8.2. Israel: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.6.8.3. Israel: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.6.8.4. Israel: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.6.8.5. Israel: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.9. DNA Diagnostics Market - South Africa
- 10.6.9.1. South Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.6.9.2. South Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.6.9.3. South Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.6.9.4. South Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.6.9.5. South Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.6.10. DNA Diagnostics Market - Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.6.10.2. Rest of Middle East & Africa: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.6.10.3. Rest of Middle East & Africa: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.6.10.4. Rest of Middle East & Africa: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.6.10.5. Rest of Middle East & Africa: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7. DNA Diagnostics Market - Latin America
- 10.7.1. Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.7.2. Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.7.3. Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.7.4. Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.7.5. Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7.6. DNA Diagnostics Market - Mexico
- 10.7.6.1. Mexico: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.7.6.2. Mexico: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.7.6.3. Mexico: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.7.6.4. Mexico: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.7.6.5. Mexico: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7.7. DNA Diagnostics Market - Brazil
- 10.7.7.1. Brazil: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.7.7.2. Brazil: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.7.7.3. Brazil: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.7.7.4. Brazil: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.7.7.5. Brazil: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7.8. DNA Diagnostics Market - Argentina
- 10.7.8.1. Argentina: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.7.8.2. Argentina: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.7.8.3. Argentina: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.7.8.4. Argentina: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.7.8.5. Argentina: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
- 10.7.9. DNA Diagnostics Market - Rest of Latin America
- 10.7.9.1. Rest of Latin America: DNA Diagnostics Market, by Offering, 2020-2034 (USD billion)
- 10.7.9.2. Rest of Latin America: DNA Diagnostics Market, by Technology, 2020-2034 (USD billion)
- 10.7.9.3. Rest of Latin America: DNA Diagnostics Market, by Specimen, 2020-2034 (USD billion)
- 10.7.9.4. Rest of Latin America: DNA Diagnostics Market, by Application, 2020-2034 (USD billion)
- 10.7.9.5. Rest of Latin America: DNA Diagnostics Market, by End User, 2020-2034 (USD billion)
11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
12. Company Profiles
- 12.1. Abbott
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Agilent Technologies, Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Avalon GloboCare Corp.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Beckman Coulter, Inc.
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. Bio-Rad Laboratories, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Cepheidc
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. F. Hoffmann-La Roche Ltd
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. GE HealthCare
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Hologic, Inc.
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Illumina, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
- 12.11. Siemens Healthcare Private Limited
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Benchmarking
- 12.11.4. Recent Development
- 12.12. Thermo Fisher Scientific Inc.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Benchmarking
- 12.12.4. Recent Development
샘플 요청 목록